Program designed to combat prescription drug abuse by expanding home Rx drug disposal options
MINNEAPOLIS (August 12, 2015) —The prescription drug problem often starts in our own homes where leftover prescription drugs sit on shelves or in medicine cabinets, where children, adolescents and visitors have easy access. It’s estimated that 70 percent of prescription opioid abusers obtain drugs from friends or family. To combat a growing prescription drug epidemic, Verde Technologies announced today that it is partnering with the Delaware Prescription Drug Action Committee (PDAC) and the Delaware Pharmacists Society (DPS) to launch the first Deterra Drug Deactivation System statewide pilot program in the country.
Verde will work with Delaware pharmacists to provide free Deterra Drug Deactivation System packages to residents so that they may safely and conveniently deactivate and dispose of unused highly addictive and sought after prescription medications at home. The goal of the program is to build public awareness of the prescription drug abuse epidemic, expand consumer disposal options and provide a cost-effective way for residents to reduce prescription drug abuse and ensure environmentally friendly disposal methods.
Drug use overdose death rates have more than tripled in Delaware and across the U.S. since 1999. Since 2010, more Delawareans have died from drug overdoses than from any other cause of unintentional injury including motor vehicle accidents. What’s more, with 70 percent of prescription opioid abusers obtaining drugs from friends or family, the problem can start at home where leftover prescription drugs sit on shelves or in medicine cabinets, with easy access to any one.
“We must take a multi-faceted approach to reducing prescription drug abuse in Delaware,” says Dr. Karyl Rattay, MD, co-chair of the PDAC and Delaware Division of Public Health (DPH) director. “Safe and secure disposal is a vital part of keeping drugs out of the hands of the wrong people and protecting our water supply. This statewide pilot is an important step in the right direction.”
“As the first state to pioneer the Deterra in-home deactivation and disposal program, Delaware is on the forefront of a major public movement that will lead other states across the country to provide cost-effective, easy-to-use tools to its citizens to combat prescription drug abuse,” says Christine Horton, chief commercial officer of Verde Technologies. “The program will provide dual benefits, keeping deadly prescription drugs out of the wrong hands, as well as out of water supplies and landfills.”
Deterra works by using Molecular Adsorption Technology (MAT12™), to neutralize the active ingredients in opioid painkillers and other drugs in pill, liquid and transdermal patch forms. The Deterra System is a package containing MAT12, a proprietary activated carbon that bonds to pharmaceutical compounds when water is added, rendering the drugs ineffective and safe for disposal quickly in any setting – home, clinic or hospital. The biodegradable bags can then be put into the trash.
Twelve hundred (1,200) packages and educational information will be distributed to residents with qualifying prescriptions through the six participating pharmacies across the state starting August 18, 2015. Pharmacists will also undergo training to educate residents on the importance of safe deactivation and disposal of their leftover prescriptions when distributing Deterra. As part of the program, data will be collected to assess the program’s success in removing deadly prescription medications from the home.
“Pharmacists play a critical role in reducing prescription drug abuse by practicing responsible dispensing of painkillers and educating patients, and now the new Deterra program provides us all with a proven tool to empower patients to safely deactivate and dispose of leftover medications at home,” says Hooshang Shanehsaz, RPh, DPH and Division of Services for Aging and Adults with Physical Disabilities pharmacy director, Cardinal Health director of pharmacy and past president of the Delaware Pharmacists Society. “It offers a convenient, cost-effective way to remove medications from the home, and ultimately prevent prescription drug abuse from starting.”
Deterra will be available in New Castle County at First State Pharmacy and Market Street Pharmacy, in Kent County at Atlantic Apothecary and Bayard Pharmacy, and in Sussex County at Georgetown Pharmacy and Cape Pharmacy. For more information, contact the participating pharmacies directly, or visit www.DeterraSystem.com.
Delaware Prescription Action Committee (PDAC)
The PDAC is a public-private partnership started by the State of Delaware’s Division of Public Health and the Medical Society of Delaware to enable multiple stakeholders to work collaboratively to address the prescription drug abuse problem in Delaware. For more information on the PDAC, visit http://dhss.delaware.gov/dhss/dph/pdachome.html.
Delaware Public Health (DPH)
DPH, a division of the Department of Health and Social Services, urges Delawareans to make healthier choices with the 5-2-1 Almost None campaign: eat 5 or more fruits and vegetables each day, have no more than 2 hours of recreational screen time each day (includes TV, computer, gaming), get 1 or more hours of physical activity each day, drink almost no sugary beverages.
Delaware Pharmacists Society (DPS)
DPS is a non-profit professional association for pharmacists, technicians and pharmacy students in the State of Delaware. For more information on the DPS, visit www.dpsrx.org.
Deterra Partnership Program
To help reverse the prescription drug abuse epidemic and reduce negative impact on the environment, Verde created the Deterra partnership program for governments, advocacy groups and organizations such as manufacturers, health insurers, pharmacies, hospitals and surgery centers, community organizations and police departments. The Deterra partnership program provides a cost-effective, environmentally and socially responsible way to quell the urgent issue through distribution of the Deterra System pouches. For more information on the Deterra System or partnership program, visit www.DeterraSystem.com, or contact email@example.com.
About Verde Technologies
Minneapolis-based Verde Technologies is a privately-owned company committed to developing research-based, scientifically proven solutions to reduce drug abuse, misuse and negative environmental impact. The Deterra Drug Deactivation System is powered by patented MAT12 Molecular Adsorption Technology, which deactivates prescription drugs using proprietary activated carbon. The technology is highly effective in adsorbing and firmly binding pharmaceuticals, rendering them inactive and ineffective for misuse and safe for the environment. For more information or to order, visit www.DeterraSystem.com or follow @deterrasystem on Twitter.